CDNA vs RDNT: stock comparison and AI forecast
Caredx, Inc. (CDNA) and Radnet, Inc. (RDNT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CDNA Caredx, Inc.
- Price
- $78.56 +266.4% · 6M
- Market Cap
- $4.13B
- P/E Ratio
- 39.5x
- Size
- mid-cap
- AI Forecast
RDNT Radnet, Inc.
- Price
- $76.00 +32.2% · 6M
- Market Cap
- $5.98B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- RDNT is 1.4 times larger than CDNA by market capitalization ($5.98B against $4.13B).
- Over the last six months CDNA returned +266.4% and RDNT +32.2%.
- CDNA turns 25.9% of its revenue into net income, against -0.9% for RDNT.
- RDNT carries 2.58 times debt per unit of equity, against 0.37 times for CDNA.
- Both companies share the SEC industry classification Services-Medical Laboratories.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CDNA | RDNT |
|---|---|---|
| Market Cap | $4.13B | $5.98B |
| P/E Ratio | 39.48x | – |
| P/B Ratio | 8.83x | 5.46x |
| EPS | $1.99 | $-0.34 |
| Book Value/Share | $8.90 | $13.93 |
| Revenue/Share | $9.47 | $28.83 |
Profitability & Margins
| Metric | CDNA | RDNT |
|---|---|---|
| ROE | 27.5% | -1.9% |
| ROA | 20.1% | -0.5% |
| ROIC | 22.9% | 2.0% |
| Operating Margin | 23.2% | 3.1% |
| Net Margin | 25.9% | -0.9% |
| EBT Margin | 25.0% | 1.5% |
| Tax Rate | -3.5% | 44.9% |
Financial Health
| Metric | CDNA | RDNT |
|---|---|---|
| Current Ratio | 2.31x | 1.48x |
| Quick Ratio | 2.25x | – |
| D/E Ratio | 0.37x | 2.58x |
| Financial Leverage | 1.37x | 3.86x |
| Interest Coverage | – | 2.2x |
| Working Capital | $182M | $338M |
Cash Flow
| Metric | CDNA | RDNT |
|---|---|---|
| Operating Cash Flow | $69M | $310M |
| OCF Growth YoY | 62.2% | 18.4% |
Operational Efficiency
| Metric | CDNA | RDNT |
|---|---|---|
| Asset Turnover | 0.78x | 0.54x |
| Receivables Turnover | 10.4x | 9.4x |
| Fixed Assets Turnover | 18.4x | 2.6x |
| Days Sales Outstanding | 35 days | 39 days |
Income Statement
| Metric | CDNA | RDNT |
|---|---|---|
| Total Revenue | $497M | $2.27B |
| Operating Income | $115M | $71M |
| Net Income | $129M | -$21M |
| R&D Expense | $84M | – |
| SG&A Expense | $344M | – |
Dividend & Shareholder Information
| Metric | CDNA | RDNT |
|---|---|---|
| Shares Outstanding | 53M | 79M |
| Net Income Growth | 111.7% | – |
| EPS Growth | 80.9% | -225.9% |
CDNA vs RDNT: stock comparison and AI forecast
Which is bigger, CDNA or RDNT?
RDNT is 1.4 times larger than CDNA by market capitalization ($5.98B against $4.13B).
Which stock performed better over the last six months, CDNA or RDNT?
Over the last six months CDNA returned +266.4% and RDNT +32.2%.
Which one does Intratio's AI model rank higher, CDNA or RDNT?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.